# Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants

> **NCT05033561** · PHASE3 · COMPLETED · sponsor: **Fidec Corporation** · enrollment: 905 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** nOPV2

## Key facts

- **NCT ID:** NCT05033561
- **Lead sponsor:** Fidec Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-16
- **Primary completion:** 2022-05-24
- **Final completion:** 2022-10-25
- **Target enrollment:** 905 (ACTUAL)
- **Last updated:** 2024-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05033561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05033561, "Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05033561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*